Obigen Pharma Inc. (7876)
Market Closed
13 Aug, 05:30
TWSE TWSE Primary NT$
36. 95
-0.05
-0.1351%
NT$
- Market Cap
- P/E Ratio
- Div Yield
68,395 Volume
- Eps
NT$ 37
Previous Close Want to track 7876 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Obigen Pharma Inc. (7876) Statistics
Valuation metrics
Market Cap -
Enterprise value 3.37B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 2.84
Enterprise Value/Revenue -
Enterprise Value/EBITDA -14
Overview
Shares outstanding -
Float 48.65M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 76.57K
Average volume (90 days) 107.33K
Price summary
52-Week low 33.75
52-Week high 69
Beta -
50-Day moving average 36.21
200-Day moving average 37.28
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.13%
Return on equity -0.21%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -240.53M
Net income to common (ttm) -325.96M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 514.37M
Total cash per share (mrq) 4.81
Total debt (mrq) 81.16M
Total Debt/Equity (mrq) 5.87
Current ratio (mrq) 18.3%
Book value per share (mrq) 12.92
Cash Flow
Cash flow statement -243.26M
Levered free cash flow (LFCF) -136.91M
